Artivion (AORT): Nomura entities report 6.5% beneficial stake in 13G/A
Rhea-AI Filing Summary
Artivion, Inc. received an amended ownership report showing that Nomura Asset Management International Inc. and Nomura Investment Management Business Trust together beneficially own 3,184,974 shares of Artivion common stock. This represents 6.5% of the common stock outstanding as of June 30, 2026.
The filing states that the firms have shared voting and dispositive power over 3,184,974 shares and no sole voting or dispositive power. The ownership percentage is calculated using 48,692,000 shares outstanding, derived from 50,179,000 shares issued minus 1,487,000 treasury shares, as reported in Artivion’s Form 10-Q for the quarter ended June 30, 2026.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 3,184,974 shares
Ownership percentage: 6.5%
Shares outstanding: 48,692,000 shares
+2 more
5 metrics
Beneficial ownership
3,184,974 shares
Shares of Artivion common stock beneficially owned by Nomura entities
Ownership percentage
6.5%
Percent of Artivion common stock class beneficially owned as of June 30, 2026
Shares outstanding
48,692,000 shares
Common stock outstanding as of June 30, 2026, per Artivion Form 10-Q
Shares issued
50,179,000 shares
Common stock issued as of June 30, 2026
Treasury shares
1,487,000 shares
Common stock held in treasury as of June 30, 2026
Key Terms
beneficially owned, shared voting power, shared dispositive power, treasury shares, +1 more
5 terms
beneficially owned financial
"Amount beneficially owned: Items 5-11 of the cover pages are incorporated"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Schedule 13G regulatory
"beneficial ownership of securities are disaggregated in accordance with SEC Release"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
FAQ
What stake in Artivion (AORT) is reported by Nomura entities in this Schedule 13G/A?
Nomura Asset Management International Inc. and Nomura Investment Management Business Trust report beneficial ownership of 3,184,974 shares of Artivion common stock, representing 6.5% of the outstanding shares as of June 30, 2026.
How is the 6.5% ownership of Artivion (AORT) calculated in this filing?
The 6.5% stake is based on 48,692,000 shares of Artivion common stock outstanding, calculated from 50,179,000 issued shares minus 1,487,000 treasury shares, as reported in Artivion’s June 30, 2026 Form 10-Q.
Which Nomura entities are filers in the Artivion (AORT) Schedule 13G/A?
The filers are Nomura Asset Management International Inc. and Nomura Investment Management Business Trust, both organized in Delaware and operating from a shared Philadelphia business address.
Does this Artivion (AORT) ownership report include securities held by Nomura Holdings Inc.?
No. The filing states it excludes securities beneficially owned, if any, by Nomura Holdings Inc. and certain subsidiaries, whose ownership is disaggregated under SEC Release No. 34-39538.
What is the class of securities covered in this Artivion (AORT) Schedule 13G/A?
The report covers Artivion’s Common Stock, $0.01 par value, with CUSIP number 228903100, identifying the specific equity securities subject to the reported 6.5% beneficial ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.